Tag: hyperkalaemia

July 21, 2017 Off

EC approves marketing to Vitor Pharma’s Veltassa for hyperkalaemia

The European Commission has approved patriometer to be marketed as Veltassa in the 28 EU countries for treating hyperkalaemia in adult patients.

March 17, 2017 Off

AstraZeneca to resolve certain matters related to development of hyperkalameia powder

By Dino Mustafić

AstraZeneca’s subsidiary ZS Pharma has been developing an oral powder as a treatment for high potassium levels in the blood serum, called hyperkalaemia, for which it got a Complete Response Letter (CRL) from the Food and Drug Administration (FDA).